West Pharmaceutical Services, Inc.

NYSE:WST 주식 보고서

시가총액: US$22.3b

West Pharmaceutical Services 과거 수익 실적

과거 기준 확인 2/6

West Pharmaceutical Services은 연평균 13.8%의 비율로 수입이 증가해 온 반면, Life Sciences 산업은 수입이 증가했으며, 연간 13.9%였습니다. 매출은 연평균 9.8%의 비율로 증가했습니다. West Pharmaceutical Services의 자기자본이익률은 18.2%이고 순이익률은 17.4%입니다.

주요 정보

13.8%

수익 성장률

13.8%

EPS 성장률

Life Sciences 산업 성장21.5%
매출 성장률9.8%
자기자본 수익률18.2%
순이익17.4%
최근 수익 업데이트30 Sep 2024

최근 과거 실적 업데이트

Recent updates

West Pharmaceutical Services, Inc. Just Recorded A 27% EPS Beat: Here's What Analysts Are Forecasting Next

Oct 27
West Pharmaceutical Services, Inc. Just Recorded A 27% EPS Beat: Here's What Analysts Are Forecasting Next

West Pharma's Destocking Dilemma: Why Staying On The Sidelines Makes Sense

Oct 11

Getting In Cheap On West Pharmaceutical Services, Inc. (NYSE:WST) Is Unlikely

Sep 20
Getting In Cheap On West Pharmaceutical Services, Inc. (NYSE:WST) Is Unlikely

A Look At The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST)

Sep 02
A Look At The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST)

West Pharmaceutical Services, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

Jul 28
West Pharmaceutical Services, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

West Pharmaceutical: Continued Destocking And A High Valuation Post Q2 Results (Rating Maintained)

Jul 25

Is It Time To Consider Buying West Pharmaceutical Services, Inc. (NYSE:WST)?

Jul 15
Is It Time To Consider Buying West Pharmaceutical Services, Inc. (NYSE:WST)?

We Think West Pharmaceutical Services (NYSE:WST) Can Stay On Top Of Its Debt

Jun 27
We Think West Pharmaceutical Services (NYSE:WST) Can Stay On Top Of Its Debt

Estimating The Fair Value Of West Pharmaceutical Services, Inc. (NYSE:WST)

May 21
Estimating The Fair Value Of West Pharmaceutical Services, Inc. (NYSE:WST)

West Pharmaceutical: Pick And Shovels Of The Injectable Drug Industry

May 11

West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Yet to Catch Up With Its Share Price

Mar 30
West Pharmaceutical Services, Inc.'s (NYSE:WST) Business Is Yet to Catch Up With Its Share Price

Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?

Mar 12
Is West Pharmaceutical Services (NYSE:WST) A Risky Investment?

Why West Pharma Is Far From Done

Feb 28

West Pharmaceutical Services, Inc.'s (NYSE:WST) Intrinsic Value Is Potentially 19% Below Its Share Price

Feb 20
West Pharmaceutical Services, Inc.'s (NYSE:WST) Intrinsic Value Is Potentially 19% Below Its Share Price

West Pharmaceutical Services: Still Too Expensive After The Recent Drop

Feb 20

What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?

Jan 10
What Does West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Indicate?

West Pharmaceutical: Great Business, Not So Great Valuation

Jan 08

What West Pharmaceutical Services, Inc.'s (NYSE:WST) P/E Is Not Telling You

Dec 18
What West Pharmaceutical Services, Inc.'s (NYSE:WST) P/E Is Not Telling You

West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

Nov 27
West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

West Pharmaceutical Services: The Run Might Be Over

Oct 18

Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?

Sep 24
Is West Pharmaceutical Services, Inc. (NYSE:WST) Potentially Undervalued?

Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

Aug 22
Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

West Pharmaceutical: Revise To Buy On Exceptional Economic Characteristics

Aug 08

What Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Doing?

Jun 26
What Is West Pharmaceutical Services, Inc.'s (NYSE:WST) Share Price Doing?

West Pharmaceutical: Hard To Justify The Price

May 26

Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

May 16
Is West Pharmaceutical Services (NYSE:WST) Using Too Much Debt?

At US$330, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?

Mar 20
At US$330, Is It Time To Put West Pharmaceutical Services, Inc. (NYSE:WST) On Your Watch List?

West Pharmaceutical Services' (NYSE:WST) Soft Earnings Don't Show The Whole Picture

Feb 28
West Pharmaceutical Services' (NYSE:WST) Soft Earnings Don't Show The Whole Picture

West Pharmaceutical Q4 2022 Earnings Preview

Feb 15

West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

Jan 31
West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet

West Pharmaceutical: An Earnings Decline Seen In 2023, Shares Still Appear Expensive

Dec 19

West Pharmaceutical declares $0.19 dividend

Dec 13

Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching

Nov 29
Why West Pharmaceutical Services, Inc. (NYSE:WST) Could Be Worth Watching

수익 및 비용 분석

West Pharmaceutical Services 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.


수익 및 매출 내역

NYSE:WST 수익, 비용 및 수입 (USD Millions )
날짜수익수익G+A 비용R&D 비용
30 Sep 242,87650034269
30 Jun 242,87752534970
31 Mar 242,92956935569
31 Dec 232,95059335468
30 Sep 232,92755929966
30 Jun 232,86651932663
31 Mar 232,88455231961
31 Dec 222,88758631659
30 Sep 222,90963137756
30 Jun 222,92968635256
31 Mar 222,88168436255
31 Dec 212,83266235653
30 Sep 212,68161334052
30 Jun 212,52351931051
31 Mar 212,32642330848
31 Dec 202,14734630147
30 Sep 202,03731229144
30 Jun 201,94528629741
31 Mar 201,88826127740
31 Dec 191,84024227339
30 Sep 191,79223026239
30 Jun 191,76722925939
31 Mar 191,74521925841
31 Dec 181,71720725640
30 Sep 181,71115525740
30 Jun 181,67715125639
31 Mar 181,62713324838
31 Dec 171,59915124339
30 Sep 171,56619024539
30 Jun 171,54417624239
31 Mar 171,53518224338
31 Dec 161,50914423837
30 Sep 161,48713824137
30 Jun 161,45410223837
31 Mar 161,4268524636
31 Dec 151,4009624334
30 Sep 151,3909424032
30 Jun 151,40112324133
31 Mar 151,41113322835
31 Dec 141,42112722937
30 Sep 141,41411923039
30 Jun 141,40011523039
31 Mar 141,37610823239
31 Dec 131,36811223538

양질의 수익: WST 은 높은 수익을 보유하고 있습니다.

이익 마진 증가: WST 의 현재 순이익 이익률 (17.4%) 작년보다 낮습니다 (19.1%).


잉여현금흐름 대 수익 분석


과거 수익 성장 분석

수익추이: WST 의 수입은 지난 5년 동안 매년 13.8% 씩 증가했습니다.

성장 가속화: WST 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.

수익 대 산업: WST 은 지난 1년 동안 마이너스 수익 성장( -10.7% )을 기록하여 Life Sciences 업계 평균( -10.7% ).


자기자본 수익률

높은 ROE: WST 의 자본 수익률( 18.2% )은 낮음으로 간주됩니다.


자산 수익률


고용 자본 수익률


과거 성과가 우수한 기업 찾기